Salvatore Mascia, Continuus Pharmaceuticals CEO
January 6, 2022 09:34 AM ESTUpdated 10:12 AM
Manufacturing

MIT spin­out Con­tin­u­us calls up­on Skan­s­ka to build MA site with fed­er­al de­fense mon­ey

Josh Sullivan

A spin­out from an MIT lab has land­ed a deal with a Swedish de­vel­op­ment group to build a $125 mil­lion man­u­fac­tur­ing fa­cil­i­ty in Woburn, MA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ex­clu­sive: Drug­mak­ers plan Trump meet­ing next week amid Wash­ing­ton health shake­ups

Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies

Ko­jin Ther­a­peu­tics shuts down, cit­ing lack of in­vestor in­ter­est and com­plex sci­ence

BioN­Tech vets raise $90M Se­ries A for bis­pe­cif­ic I&I start­up

ARPA-H chief is out as Trump ad­min­is­tra­tion cuts health agen­cies

sponsored

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

A service from the Financial Times